Human Genome Project Information. Click to return to home page.

Sponsored by the U.S. Department of Energy Human Genome Program

Human Genome News Archive Edition

Human Genome News, November 1990; 2(4)

DOE Program Appoints Cantor Principal Scientist

Charles R. Cantor has been appointed Principal Scientist for the DOE Human Genome Program. In this capacity, he will assist in the coordination of the program's scientific activities and advise the three DOE genome research centers, which are located at Lawrence Livermore National Laboratory (LLNL), Lawrence Berkeley Laboratory (LBL), and Los Alamos National Laboratory (LANL).

To devote his efforts to these new responsibilities, Cantor has resigned his position as Director of the LBL Human Genome Center. He will continue to chair the DOE Human Genome Coordinating Committee and serve as a regional Vice President of the international Human Genome Organisation (HUGO).

"I am delighted to have this opportunity to play a central role in a program of historical importance for biology and medicine," said Cantor.

DOE Associate Director David J. Galas, Office of Health and Environmental Research, said, "The DOE genome program is indeed fortunate to have Charles Cantor take on this new program-wide role for scientific guidance and coordination. We look forward to working closely with him."

The genome research centers at LLNL, LANL, and LBL were established by DOE to construct physical maps of chromosomes and to develop the technology for mapping, sequencing, and deciphering this information.

Cantor headed the Human Genome Center at LBL, managed for DOE by the University of California, for 2 years. He will remain at Berkeley and, in addition to his broader role, serve in an advisory capacity to LBL Director Charles V. Shank.

"LBL is indebted to Dr. Cantor for his efforts on behalf of our Human Genome Center," said Shank. "As an internationally recognized expert in the fields of genetic mapping and sequencing, he is a valuable scientific resource, and I am pleased we will continue to have the benefit of his counsel."

Charles Cantor received his A.B. from Columbia University and his Ph.D. from the University of California, Berkeley. He was codeveloper with David Schwartz of the widely used pulsed-field gel electrophoresis technique [Cell 37 (1): 67-75 (1984)].

Cantor is a Guggenheim Fellow, Fellow of the American Association for the Advancement of Science, and an Alfred P. Sloan Foundation Fellow. In 1978 he received the Eli Lilly Award in Biological Chemistry and in 1985 an Outstanding Investigator Grant from the National Cancer Institute. He was elected to the National Academy of Sciences in 1988 and is a founding member of HUGO.


Return to Table of Contents

The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v2n4).

Human Genome Project 1990–2003

The Human Genome Project (HGP) was an international 13-year effort, 1990 to 2003. Primary goals were to discover the complete set of human genes and make them accessible for further biological study, and determine the complete sequence of DNA bases in the human genome. See Timeline for more HGP history.

Human Genome News

Published from 1989 until 2002, this newsletter facilitated HGP communication, helped prevent duplication of research effort, and informed persons interested in genome research.